BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16334167)

  • 21. Identification of MHC class II-restricted T-cell epitopes in prostate-specific membrane antigen.
    Schroers R; Shen L; Rollins L; Xiao Z; Sonderstrup G; Slawin K; Huang XF; Chen SY
    Clin Cancer Res; 2003 Aug; 9(9):3260-71. PubMed ID: 12960111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Domestication of suspension CHO cells and its application in the expression of anti-PSMA antibody].
    Wu J; Han D; Wei M; Zheng G; Jiao D; Xi W; Yang A; Qin W; Wen W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jan; 32(1):1-4. PubMed ID: 27358992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.
    Knight D; Peterson AC; Rini BI; Harlin H; Gajewski TF; Stadler WM
    Prostate; 2009 Feb; 69(2):142-8. PubMed ID: 18942640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer.
    Wolf P; Freudenberg N; Bühler P; Alt K; Schultze-Seemann W; Wetterauer U; Elsässer-Beile U
    Prostate; 2010 Apr; 70(5):562-9. PubMed ID: 19938014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen.
    Slovin SF
    Expert Opin Ther Targets; 2005 Jun; 9(3):561-70. PubMed ID: 15948673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-prostate cancer effects of CTL cell induction in vitro by recombinant adenovirus mediated PSMA/4-1BBL dendritic cells: an immunotherapy study.
    Sui CG; Wu D; Meng FD; Yang MH; Jiang YH
    Genet Mol Res; 2015 Jun; 14(2):7208-17. PubMed ID: 26125931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunological response of mice induced by recombinant adenovirus carrying rat prostate-specific membrane antigen gene].
    Wang SJ; Zhang DM; Yang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):147-51. PubMed ID: 21500542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene.
    O'Keefe DS; Bacich DJ; Heston WD
    Prostate; 2004 Feb; 58(2):200-10. PubMed ID: 14716746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of naturally processed helper T-cell epitopes from prostate-specific membrane antigen using peptide-based in vitro stimulation.
    Kobayashi H; Omiya R; Sodey B; Yanai M; Oikawa K; Sato K; Kimura S; Senju S; Nishimura Y; Tateno M; Celis E
    Clin Cancer Res; 2003 Nov; 9(14):5386-93. PubMed ID: 14614024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts.
    Lütje S; van Rij CM; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
    Contrast Media Mol Imaging; 2015; 10(1):28-36. PubMed ID: 24764162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Verification of a canine PSMA (FolH1) antibody.
    Wagner S; Maibaum D; Pich A; Nolte I; Murua Escobar H
    Anticancer Res; 2015 Jan; 35(1):145-8. PubMed ID: 25550545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate specific membrane antigen (PSMA) is a tissue-specific target for adenoviral transduction of prostate cancer in vitro.
    Kraaij R; van Rijswijk AL; Oomen MH; Haisma HJ; Bangma CH
    Prostate; 2005 Feb; 62(3):253-9. PubMed ID: 15389777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of antitumour immunity by a novel chemotactic antigen DNA vaccine encoding chemokines and multiepitopes of prostate-tumour-associated antigens.
    Qin H; Zhou C; Wang D; Ma W; Liang X; Lin C; Zhang Y; Zhang S
    Immunology; 2006 Mar; 117(3):419-30. PubMed ID: 16476062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.
    Evazalipour M; D'Huyvetter M; Tehrani BS; Abolhassani M; Omidfar K; Abdoli S; Arezumand R; Morovvati H; Lahoutte T; Muyldermans S; Devoogdt N
    Contrast Media Mol Imaging; 2014; 9(3):211-20. PubMed ID: 24700748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A chemically induced vaccine strategy for prostate cancer.
    Dubrovska A; Kim C; Elliott J; Shen W; Kuo TH; Koo DI; Li C; Tuntland T; Chang J; Groessl T; Wu X; Gorney V; Ramirez-Montagut T; Spiegel DA; Cho CY; Schultz PG
    ACS Chem Biol; 2011 Nov; 6(11):1223-31. PubMed ID: 21936526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers.
    Zhang S; Zhang HS; Reuter VE; Slovin SF; Scher HI; Livingston PO
    Clin Cancer Res; 1998 Feb; 4(2):295-302. PubMed ID: 9516914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system.
    Arndt C; Feldmann A; Koristka S; Cartellieri M; Dimmel M; Ehninger A; Ehninger G; Bachmann M
    Prostate; 2014 Sep; 74(13):1335-46. PubMed ID: 25053443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen.
    Cao KY; Mao XP; Wang DH; Xu L; Yuan GQ; Dai SQ; Zheng BJ; Qiu SP
    Prostate; 2007 Dec; 67(16):1791-800. PubMed ID: 17929272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.